UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 196

Sortiert nach

Human lectins and their roles in viral infections

Molecules, 2015-01, Vol.20 (2), p.2229-2271

2015

Link zum Volltext

Verfügbarkeit prüfen

Automated Redistricting Simulation Using Markov Chain Monte Carlo

Journal of computational and graphical statistics, 2020-10, Vol.29 (4), p.715-728

2020

Link zum Volltext

Verfügbarkeit prüfen

The past, present and future of neutralizing antibodies for hepatitis C virus

Antiviral research, 2014-05, Vol.105 (100), p.100-111

2014

Link zum Volltext

Verfügbarkeit prüfen

Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination

Annals of neurology, 2021-08, Vol.90 (2), p.315-318

2021

Link zum Volltext

Verfügbarkeit prüfen

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

Nature medicine, 2008-01, Vol.14 (1), p.25-27

2008

Link zum Volltext

Verfügbarkeit prüfen

Colicin import into E. coli cells: A model system for insights into the import mechanisms of bacteriocins

Biochimica et biophysica acta, 2014-08, Vol.1843 (8), p.1717-1731

2014

Link zum Volltext

Verfügbarkeit prüfen

Think regionally, act locally?: gardening, cycling, and the horizon of urban spatial politics

Urban geography, 2017-10, Vol.38 (9), p.1329-1351

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus Vaccine: Challenges and Prospects

Vaccines (Basel), 2020-02, Vol.8 (1), p.90

2020

Link zum Volltext

Verfügbarkeit prüfen

Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies

Journal of virology, 2015-02, Vol.89 (4), p.2170-2181

2015

Link zum Volltext

Verfügbarkeit prüfen

Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants

Journal of hepatology, 2019-04, Vol.70 (4), p.593-602

2019

Link zum Volltext

Verfügbarkeit prüfen

Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy?

International journal of pharmaceutics, 2018-08, Vol.547 (1-2), p.572-581

2018

Link zum Volltext

Verfügbarkeit prüfen

Human Bocavirus infection and respiratory tract disease identified in a UK patient cohort

Journal of clinical virology, 2020-08, Vol.129, p.104453-104453, Article 104453

2020

Link zum Volltext

Verfügbarkeit prüfen

Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus

Journal of general virology, 2022-11, Vol.103 (11)

2022

Link zum Volltext

Verfügbarkeit prüfen

Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response

The Journal of infectious diseases, 2022-06, Vol.225 (12), p.2142-2154

2022

Link zum Volltext

Verfügbarkeit prüfen

Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection

Science translational medicine, 2021-09, Vol.13 (609), p.eabj0847

2021

Link zum Volltext

Verfügbarkeit prüfen

Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design

Viruses, 2015-07, Vol.7 (7), p.3995-4046

2015

Link zum Volltext

Verfügbarkeit prüfen

Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021

Pediatric nephrology (Berlin, West), 2023-11, Vol.38 (11), p.3745-3755

2023

Link zum Volltext

Verfügbarkeit prüfen

An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (2), p.562-574

2022

Link zum Volltext

Verfügbarkeit prüfen

Sero-reactivity to three distinct regions within the hepatitis C virus alternative reading frame protein (ARFP/core+1) in patients with chronic HCV genotype-3 infection

Journal of general virology, 2022-03, Vol.103 (3)

2022

Link zum Volltext

Verfügbarkeit prüfen

Scavenger receptor class B type I genetic variants associated with disease severity in chronic hepatitis C virus infection

Journal of medical virology, 2023-01, Vol.95 (1), p.e28331-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination

Journal of medical virology, 2023-01, Vol.95 (1), p.e28178-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance

Journal of hepatology, 2019-07, Vol.71 (1), p.14-24

2019

Link zum Volltext

Verfügbarkeit prüfen

An alpaca nanobody inhibits hepatitis C virus entry and cell‐to‐cell transmission

Hepatology (Baltimore, Md.), 2013-09, Vol.58 (3), p.932-939

2013

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Journal of Virology, 2005-09, Vol.79 (17), p.11095-11104

2005

Link zum Volltext

Verfügbarkeit prüfen

Cloning and Analysis of Authentic Patient-Derived HCV E1/E2 Glycoproteins

Methods in molecular biology (Clifton, N.J.), 2019, Vol.1911, p.275

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(185)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(196)
Japanisch
(25)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Life Sciences & Biomedicine
(105)
Humans
(83)
Virology
(39)
Microbiology
(29)
Software Engineering
(29)
Hepatitis C Virus
(28)
Hepacivirus - Genetics
(27)
Information Architecture
(25)
Biological And Medical Sciences
(22)
Viral Envelope Proteins - Genetics
(21)
Hepacivirus - Immunology
(20)
Animals
(19)
Female
(19)
Male
(19)
Viral Envelope Proteins - Immunology
(19)
Genotype
(18)
Immunology
(18)
Fundamental And Applied Biological Sciences. Psychology
(17)
Hepatitis C
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Human lectins and their roles in viral infections

Automated Redistricting Simulation Using Markov Chain Monte Carlo

The past, present and future of neutralizing antibodies for hepatitis C virus

Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

Colicin import into E. coli cells: A model system for insights into the import mechanisms of bacteriocins

Think regionally, act locally?: gardening, cycling, and the horizon of urban spatial politics

Hepatitis C Virus Vaccine: Challenges and Prospects

Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies

Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants

Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy?

Human Bocavirus infection and respiratory tract disease identified in a UK patient cohort

Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus

Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response

Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection

Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design

Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021

An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development

Sero-reactivity to three distinct regions within the hepatitis C virus alternative reading frame protein (ARFP/core+1) in patients with chronic HCV genotype-3 infection

Scavenger receptor class B type I genetic variants associated with disease severity in chronic hepatitis C virus infection

Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination

Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance

An alpaca nanobody inhibits hepatitis C virus entry and cell‐to‐cell transmission

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Cloning and Analysis of Authentic Patient-Derived HCV E1/E2 Glycoproteins

Suchergebnisse filtern